Ferric Carboxymaltose in Heart Failure with Iron Deficiency.


Journal

The New England journal of medicine
ISSN: 1533-4406
Titre abrégé: N Engl J Med
Pays: United States
ID NLM: 0255562

Informations de publication

Date de publication:
14 Sep 2023
Historique:
medline: 15 9 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the effects of ferric carboxymaltose on clinical events is needed. In this double-blind, randomized trial, we assigned ambulatory patients with heart failure, a left ventricular ejection fraction of 40% or less, and iron deficiency, in a 1:1 ratio, to receive intravenous ferric carboxymaltose or placebo, in addition to standard therapy for heart failure. Ferric carboxymaltose or placebo was given every 6 months as needed on the basis of iron indexes and hemoglobin levels. The primary outcome was a hierarchical composite of death within 12 months after randomization, hospitalizations for heart failure within 12 months after randomization, or change from baseline to 6 months in the 6-minute walk distance. The significance level was set at 0.01. We enrolled 3065 patients, of whom 1532 were randomly assigned to the ferric carboxymaltose group and 1533 to the placebo group. Death by month 12 occurred in 131 patients (8.6%) in the ferric carboxymaltose group and 158 (10.3%) in the placebo group; a total of 297 and 332 hospitalizations for heart failure, respectively, occurred by month 12; and the mean (±SD) change from baseline to 6 months in the 6-minute walk distance was 8±60 and 4±59 m, respectively (Wilcoxon-Mann-Whitney P = 0.02; unmatched win ratio, 1.10; 99% confidence interval, 0.99 to 1.23). Repeated dosing of ferric carboxymaltose appeared to be safe with an acceptable adverse-event profile in the majority of patients. The number of patients with serious adverse events occurring during the treatment period was similar in the two groups (413 patients [27.0%] in the ferric carboxymaltose group and 401 [26.2%] in the placebo group). Among ambulatory patients who had heart failure with a reduced ejection fraction and iron deficiency, there was no apparent difference between ferric carboxymaltose and placebo with respect to the hierarchical composite of death, hospitalizations for heart failure, or 6-minute walk distance. (Funded by American Regent, a Daiichi Sankyo Group company; HEART-FID ClinicalTrials.gov number, NCT03037931.).

Sections du résumé

BACKGROUND BACKGROUND
Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the effects of ferric carboxymaltose on clinical events is needed.
METHODS METHODS
In this double-blind, randomized trial, we assigned ambulatory patients with heart failure, a left ventricular ejection fraction of 40% or less, and iron deficiency, in a 1:1 ratio, to receive intravenous ferric carboxymaltose or placebo, in addition to standard therapy for heart failure. Ferric carboxymaltose or placebo was given every 6 months as needed on the basis of iron indexes and hemoglobin levels. The primary outcome was a hierarchical composite of death within 12 months after randomization, hospitalizations for heart failure within 12 months after randomization, or change from baseline to 6 months in the 6-minute walk distance. The significance level was set at 0.01.
RESULTS RESULTS
We enrolled 3065 patients, of whom 1532 were randomly assigned to the ferric carboxymaltose group and 1533 to the placebo group. Death by month 12 occurred in 131 patients (8.6%) in the ferric carboxymaltose group and 158 (10.3%) in the placebo group; a total of 297 and 332 hospitalizations for heart failure, respectively, occurred by month 12; and the mean (±SD) change from baseline to 6 months in the 6-minute walk distance was 8±60 and 4±59 m, respectively (Wilcoxon-Mann-Whitney P = 0.02; unmatched win ratio, 1.10; 99% confidence interval, 0.99 to 1.23). Repeated dosing of ferric carboxymaltose appeared to be safe with an acceptable adverse-event profile in the majority of patients. The number of patients with serious adverse events occurring during the treatment period was similar in the two groups (413 patients [27.0%] in the ferric carboxymaltose group and 401 [26.2%] in the placebo group).
CONCLUSIONS CONCLUSIONS
Among ambulatory patients who had heart failure with a reduced ejection fraction and iron deficiency, there was no apparent difference between ferric carboxymaltose and placebo with respect to the hierarchical composite of death, hospitalizations for heart failure, or 6-minute walk distance. (Funded by American Regent, a Daiichi Sankyo Group company; HEART-FID ClinicalTrials.gov number, NCT03037931.).

Identifiants

pubmed: 37632463
doi: 10.1056/NEJMoa2304968
doi:

Substances chimiques

ferric carboxymaltose 6897GXD6OE
Ferric Compounds 0

Banques de données

ClinicalTrials.gov
['NCT03037931']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

975-986

Investigateurs

Carmine De Pasquale (C)
Michael Stokes (M)
Isuru Ranasinghe (I)
Alicia Chan (A)
Matthew Best (M)
Kaitlyn Lam (K)
John Atherton (J)
Yee Weng Wong (YW)
Scott McKenzie (S)
Steven Sutcliffe (S)
David Cross (D)
John Amerena (J)
Hendrik Zimmet (H)
Matthew Marrinan (M)
David Colquhoun (D)
Peter MacDonald (P)
Laurie Howes (L)
Gayathri Kumarasinghe (G)
John French (J)
Nathan Dwyer (N)
Aaron Sverdlov (A)
Valentina Grigorova (V)
Katerina Vitliyanova (K)
Ivan Martinov (I)
Maria Tzekova (M)
Miroslav Stoyanov (M)
Bojidar Dimov (B)
Ivan Efremov (I)
Ivaylo Vasilev (I)
Georgi Todorov (G)
Valentina Mincheva-Kabakchieva (V)
Haralambi Benov (H)
Yordan Dzhumean (Y)
Savka Vaklyova (S)
Tanya Petkova (T)
Sebastien Bergeron (S)
Sudip Datta (S)
Brian Clarke (B)
Robert Miller (R)
Danielle Dion (D)
Ryan Davey (R)
Justin Ezekowitz (J)
Nadia Giannetti (N)
Mikael Hanninen (M)
Amit Khosla (A)
Dante Manyari (D)
Gordon Moe (G)
Eileen O'Meara (E)
Amritanshu Pandey (A)
John Parker (J)
Yves Pesant (Y)
Miroslaw Rajda (M)
Richard Vandegriend (R)
Denis Saulnier (D)
Ying Tung Sia (YT)
Bruce Sussex (B)
Elizabeth Swiggum (E)
Mustafa Toma (M)
Alexander Zhai (A)
Saul Vizel (S)
Marc Benoit (M)
Ronald Bourgeois (R)
Martin Wiendl (M)
Ondrej Toman (O)
Jan Belohlavek (J)
Vojtech Melenovsky (V)
Anu Hedman (A)
George Khabeishvili (G)
Tamaz Shaburishvili (T)
Irakli Khintibidze (I)
Levan Kurashvili (L)
Giorgi Nikolaishvili (G)
Rusudan Agladze (R)
Teona Gvinianidze (T)
Zurab Klimiashvili (Z)
Vakhtang Chumburidze (V)
Nodar Emukhvari (N)
Andrea Hornyik (A)
Geza Lupkovics (G)
Annamaria Piros (A)
Bela Herczeg (B)
Zeno Ajtay (Z)
Zoltan Csanadi (Z)
Andras Nagy (A)
Orsolya Balogh (O)
Bela Merkely (B)
Iveta Sime (I)
Natalja Kakurina (N)
Dalia Jarasuniene (D)
Jelena Celutkiene (J)
Gintare Sakalyte (G)
Jocelyne Benatar (J)
Hamish Hart (H)
Patrick Gladding (P)
Mayanna Lund (M)
John Baker (J)
Ian Ternouth (I)
Andrew Corin (A)
Richard Luke (R)
Timothy O'Meeghan (T)
Scott Harding (S)
Alyssa Kirby (A)
Tammy Pegg (T)
Richard Troughton (R)
Gerard Wilkins (G)
Craig King (C)
Gerard Devlin (G)
Susan DeCaigney (S)
Piotr Abramczyk (P)
Maciej Zabowka (M)
Bartosz Krakowiak (B)
Mariusz Kafara (M)
Marta Obremska (M)
Marcin Ogorek (M)
Grzegorz Skonieczny (G)
Joanna Szachniewicz (J)
Marzena Janik-Palazzolo (M)
Zbigniew Gaciong (Z)
Slawomir Tyminski (S)
Grzegorz Sobieszek (G)
Ryszard Sciborski (R)
Ewa Underman (E)
Piotr Paluszek (P)
Elizaveta Antonova (E)
Irina Shumikhina (I)
Olga Reshetko (O)
Dmitriy Nosovich (D)
Vasily Vasilyuk (V)
Rostislav Nilk (R)
Tamara Pecherina (T)
Zhanna Kobalava (Z)
Victor Kostenko (V)
Anatoly Kuzin (A)
Yury Shvarts (Y)
Philipp Kopylov (P)
Sergey Yakushin (S)
Oleksandr Karpenko (O)
Oksana Reshotko (O)
Igor Vakaliuk (I)
Valentyn Maslovskyi (V)
Halyna Myshanych (H)
Liudmila Alieksieieva (L)
Andriy Faynyk (A)
Larysa Mishchenko (L)
Leonid Rudenko (L)
Sergiy Dotsenko (S)
Mykhaylo Kolesnyk (M)
Vira Tseluyko (V)
Ivan Vyshnyvetskyy (I)
Igor Kyrychenko (I)
Yuriy Mostovoy (Y)
Nadiya Tryshchuk (N)
Larysa Rudik (L)
Andriy Bazylevych (A)
Anna Veselova (A)
Oleksandr Palamarchuk (O)
Sergey Kozhukhov (S)
Oleksandr Bondarchuk (O)
Ashwin Ravichandran (A)
Masoud Azizad (M)
Majed Chane (M)
Samuel Butman (S)
Eugene Soroka (E)
Alex Schabauer (A)
Ankie Amos (A)
Venkata Alla (V)
Steven Krueger (S)
Gina Mentzer (G)
Afshine Emrani (A)
Samir Turk (S)
Arash Vahdat (A)
William French (W)
Ira Dauber (I)
Margaret Redfield (M)
Brenda Peart (B)
Vivek Bhatia (V)
Bryan Fuhs (B)
Peter Eckman (P)
Stephen Miller (S)
Gautam Nayak (G)
Lydie Hazan (L)
Maleah Grover-McKay (M)
Priya Kumar (P)
Christopher Chow (C)
Edward Chu (E)
Fahed Bitar (F)
Farhad Rafii (F)
William Davis (W)
Benjamin Trichon (B)
Hemant Goyal (H)
Jeffrey Stephens (J)
Paul Rosenberg (P)
Christopher Chien (C)
Mary Ann Peberdy (MA)
David Sane (D)
Matthew Janik (M)
Arthur Bleakley Chandler (A)
Shahyar Gharacholou (S)
Christopher Malozzi (C)
Michael Morris (M)
Felix Sogade (F)
Brian Foley (B)
F Martin Lester (FM)
Shuaib Abdullah (S)
Michael Radin (M)
Naeem Tahirkheli (N)
Kelley Anderson (K)
Kanagaratnam Sivalingam (K)
David Hinchman (D)
Dharmendra Patel (D)
Donald Haas (D)
Abdul-Nasser Adjei (AN)
David Smith (D)
Magdalene Marfo (M)
Elmer Stout (E)
Antonio Blanco (A)
Sammy Cox (S)
Vedampattu Ganeshram (V)
Alan Chu (A)
Joaquin Martinez-Arraras (J)
Thomas Buzbee (T)
Raymond Little (R)
Martin Berk (M)
John Kobayashi (J)
Bruce Iteld (B)
Malcolm Foster (M)
Jamil Malik (J)
Wayne Gray (W)
Michael Barron (M)
Vijay Rao (V)
Atul Chugh (A)
Faizan Iftikhar (F)
Milan Sheth (M)
Theodore Takata (T)
Mika Takata (M)
Venkata Chilakapati (V)
Muhammad Khan (M)
Zafir Hawa (Z)
David Hahn (D)
Roy Robertson (R)
Neerav Shah (N)
Duccio Baldari (D)
Gregory Alfred (G)
Gladys Andrade (G)
Miguel Trevino (M)
Peter Fail (P)
Javier Colomar (J)
Ghiath Mikdadi (G)
Anisia Otero (A)
Ramon Alegret (R)
Barry Bertolet (B)
Nirav Raval (N)
Ioana Dumitru (I)
Shelley Hall (S)
Eulogio Sanchez (E)
Reynolds Delgado (R)
Stuart Russell (S)
Alan Maisel (A)
William Penny (W)
Jalal Abbas (J)
Jagdeep Sabharwal (J)
Matthew Weinberg (M)
Lazaros Nikolaidis (L)
Jagadeesh Ganji (J)
Sandeep Khosla (S)
Philip O'Donnell (P)
Dennis Spiller (D)
David Baran (D)
Wayne Old (W)
Richard Grodman (R)
Muzamil Rana (M)
David Avino (D)
David His (D)
Terry Wells (T)
Michael Huber (M)
Ademola Abiose (A)
John Prodafikas (J)
Ira Friedlander (I)
Howard Eisen (H)
Syed Hasni (S)
Greg Kumkumian (G)
Lance Berger (L)
Rajeev Sudhakar (R)
Naveed Akhtar (N)
David Dobies (D)
Samuel Coffin (S)
Ehab Sorial (E)
Johannes Steiner (J)
Peter Van Buren (P)
Ashish Parikh (A)
Lindsay Castle (L)
Amit Varma (A)
Alaa Shalaby (A)
Sitaramesh Emani (S)
Sayed Rizvi (S)
Abbas Shehadeh (A)
Andreas Wali (A)
Rajesh Dave (R)
Khalil Murad (K)
Hal Skopick (H)
Carol Gemayel-Barra (C)
Michael Hong (M)
Brian Snyder (B)
Vineshkumar Patel (V)
James Welker (J)
Jeffrey Banker (J)
Chaitanya Ravi (C)
Mauro Moscucci (M)
Andrey Espinoza (A)
Anuradha Lala-Trindade (A)
Jesus Rodriguez de la Torre (J)
Sourin Banerji (S)
Jerry Estep (J)
Mazen Hanna (M)
Erin Coglianese (E)
Rosa Suarez (R)
Sandor Romero (S)
Rohit Amin (R)
Raguveer Murthy (R)
Gil Vardi (G)
Naseem Jaffrani (N)
Omar Almousalli (O)
John Lehman (J)
John McGinty (J)
Michael Miyamoto (M)
Patrick Simpson (P)
Arun Krishnamoorthy (A)
Andrew Darlington (A)
Catherine Marti (C)
Fadi Saba (F)
Vipul Shah (V)
Misal Khan (M)
Francesco Franchi (F)
Brian Schietinger (B)
Ambar Patel (A)
Surya Rao (S)
Brent Videau (B)
Bruce Rankin (B)
Seth Baker (S)
Marwa Sabe (M)
Lawrence Weinstein (L)
William McGuinn (W)
Felix Chion-Fong (F)
Norman Lepor (N)
Patrick McCann (P)
Chrisette Dharma (C)
Thomas Folk (T)
John Heitner (J)
Kumudha Ramasubbu (K)
Neil Lewis (N)
Frank McGrew (F)
Adrian F Hernandez (AF)
Robert J Mentz (RJ)
Javed Butler (J)
Carmine G De Pasquale (CG)
Justin A Ezekowitz (JA)
Gregory D Lewis (GD)
Eileen O'Meara (E)
Piotr Ponikowski (P)
Richard W Troughton (RW)
Robert Adamczyk (R)
Tetyana Storie (T)
Nicole Blackman (N)
Denise Aguilar (D)
James Bambrick (J)
Kathleen Moriarty (K)
Angelo Secci (A)
Erin Malloy (E)
Victor Ahuruonye (V)
Sharon Califf (S)
Andrew P Ambrosy (AP)
Dottie Blythe (D)
Shanna Carlino (S)
Brenda Franklin-Goode (B)
Jyotsna Garg (J)
Josephine Harrington (J)
Paula Lavender (P)
Stacey Mangum (S)
Lynn Perkins (L)
Marc D Samsky (MD)
Dimitrios Stournaras (D)
Christina Wilson (C)
Dianne LeLoudis (D)
Frank Rockhold (F)
Tracy Temple (T)
Courtney Gubbels (C)
Liddy Griffith (L)
Julie Butters (J)
Domenic Sacca (D)
Caroline Alsweiler (C)
Harvey White (H)
Katharina Lange (K)
Sergii Iesipov (S)
Sylwia Wojcik (S)
W Schuyler Jones (WS)
Adam DeVore (A)
Angela Lowenstern (A)
Chiara Melloni (C)
Jay Shavadia (J)
Marat Fudim (M)
Bradley Kolls (B)
David Kong (D)
Jennifer Rymer (J)
Stephen Greene (S)
Robert Harrison (R)
Robert McGarrah (R)
Dedrick Jordan (D)
Rajendra Mehta (R)
Renato Lopes (R)
Thomas Povsic (T)
Keith Dombrowski (K)
Luciano Sposato (L)
Michael Nanna (M)
Sarah Goldstein (S)
Guillaume Marquis-Gravel (G)
Michel Zeitouni (M)
Zak Loring (Z)
J Antonio Gutierrez (JA)
Jennifer Green (J)
Zachary Wegermann (Z)
Robin Mathews (R)
Gerald Bloomfield (G)
Derek Soon Ler Chew (DSL)
Karen Alexander (K)
Larry Jackson (L)
Michelle Kelsey (M)
Vishal Rao (V)
Sana Al-Khatib (S)
Kelly Arps (K)
Anthony Peters (A)
Vanessa Blumer (V)
Konstantin Krychtiuk (K)
Daniel Guidot (D)
Joseph Lerman (J)
Alexander Graham (A)
Kenneth Mahaffey (K)
David DeMets (D)
Shaun Goodman (S)
Barry Greenberg (B)
Marvin Konstam (M)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2023 Massachusetts Medical Society.

Auteurs

Robert J Mentz (RJ)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Jyotsna Garg (J)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Frank W Rockhold (FW)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Javed Butler (J)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Carmine G De Pasquale (CG)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Justin A Ezekowitz (JA)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Gregory D Lewis (GD)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Eileen O'Meara (E)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Piotr Ponikowski (P)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Richard W Troughton (RW)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Yee Weng Wong (YW)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Lilin She (L)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Josephine Harrington (J)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Robert Adamczyk (R)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Nicole Blackman (N)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Adrian F Hernandez (AF)

From the Division of Cardiology, Department of Medicine (R.J.M., J.H., A.F.H.), and the Department of Biostatistics and Bioinformatics (F.W.R.), Duke University School of Medicine, and Duke Clinical Research Institute (R.J.M., J.G., F.W.R., L.S., J.H., A.F.H.) - both in Durham, NC; Baylor Scott and White Research Institute, Dallas (J.B.); the Department of Medicine, University of Mississippi, Jackson (J.B.); Flinders Medical Centre, Flinders University, Adelaide, SA (C.G.D.P.), and the Department of Cardiology, Prince Charles Hospital and Faculty of Medicine, University of Queensland, Brisbane (Y.W.W.) - both in Australia; Canadian VIGOUR Centre, University of Alberta, Edmonton (J.A.E.), and Montreal Heart Institute and Université de Montréal, Montreal (E.O.) - both in Canada; the Cardiology Division and Cardiovascular Research Center, Massachusetts General Hospital, Boston (G.D.L.); the Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.); Christchurch Heart Institute, University of Otago, Christchurch, New Zealand (R.W.T.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.W.W.); and American Regent, Shirley, NY (R.A., N.B.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH